AimwellBio Secures Proprietary Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors

PartnershipPositive

AI Analysis

Summary

AimwellBio has secured a proprietary behavioral AI portfolio backed by Oxford Science and Sanofi through a pilot program, with Dr. Chris A. Jones joining the company's Board of Advisors.

Importance:5/10

Sentiment:

0.60

partnershipAIbehavioral_healthboard_appointment

Related Companies

$SNY $ONT.L

Read the original article

Published by yahoo_finance on August 17, 2026 12:45 PM

Read Original